Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma

The study aims to investigate potential diagnostic and prognostic value of immunohistochemical expression of Nestin, a progenitor cell marker, in a large series of 1,050 primary liver cancer samples collected from multiple institutes across the US, Europe and Asia.

The research utilised Crosscope’s cloud-based software for pathology reviews of digital slides. The representative slides can be available here.

Read the full paper here.

Access Article